BriaCell Therapeutics starts dosing in Phase I/IIa trial of Bria-IMT
BriaCell Therapeutics has started dosing patients in a Phase I/IIa trial to evaluate Bria-IMT in...
BriaCell Therapeutics has started dosing patients in a Phase I/IIa trial to evaluate Bria-IMT in...